Oncologix Tech, Inc. (OTCPK:OCLG) announced a private placement of 2,000,000 common shares at a price of $0.01 per share and a convertible note for gross proceeds of $120,000 on January 8, 2013. The company issued the shares to three non-related accredited investors. In connection with convertible note part the company also issued warrant to a non-related accredited investor. The note and warrant are convertible into common stock of the company at a fixed price of $0.009 per share. The company issued securities pursuant to exemption provided under Regulation D. In connection with convertible note part the company also paid a finder's fee of $5,000.


On January 8, 2013, Oncologix Tech, Inc. closed the transaction.